Long-term follow-up after the mini-maze procedure

Szalay, Z.; Civelek, Ali; Dill, Thorsten; Klövekorn, W. P.; Kilb, Iram; Bauer, Erwin

doi:10.1016/j.athoracsur.2003.09.057

Cited by 12 publications

(4 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Exploration of additional risk factors related to survival and rhythm outcome might allow improved therapy strategies for patients with AF intended to be treated with valve surgery and the maze procedure. In this study, in line with previous reports [4,7,[10][11][12][13], we report that AF at discharge and/or during follow-up is related to lower survival in this patient cohort. Moreover, we find that thrombocytopenia, elevated serum total bilirubin concentration and right atrial diameter greater than 45.5 mm are additional determinants of increased mid-term all-cause death in these patients.…”

Section: Discussionsupporting

confidence: 92%

Risk Factors for Prognosis after the Maze IV Procedure in Patients with Atrial Fibrillation Undergoing Valve Surgery

Zhou

2022

CVIA

View full text Add to dashboard Cite

The present study evaluated risk factors related to persistent atrial fibrillation (AF) at discharge (AF-d) and recurrentatrial fibrillation (rAF) and all-cause death after the maze IV procedure. Two hundred nineteen patients (63 female,aged 52.5 ± 8.8 years) with valve disease and persistent AF undergoing valve surgery and the maze IV procedure in our center between 2015 and 2016 were included. Baseline demographic and clinical data were obtained by review of medical records. The median follow-up period was 27 months (interquartile range 21–34 months) in our patient cohort.The primary end point was all-cause death. The secondary end point was AF-d or rAF. rAF is defined as AF recurrenceat 3 months or later after the procedure. Twenty-eight patients (12.8%) died during follow-up. Multiple logistic regression analysis showed that thrombocytopenia, elevated serum total bilirubin level, a larger right atrium, AF-d, and rAF were independent determinants for all-cause death after the maze IV procedure after adjustment for age, sex, and clinical covariates, including New York Heart Association class III/IV disease, hypertension, and aortic regurgitation, while valvular disease duration and left atrial diameter greater than 80.5 mm were independent determinants for AF-d, and thrombocytopenia, elevated serum total bilirubin level, higher mean pulmonary artery pressure, and AF-d were independent predictors for rAF. In conclusion, thrombocytopenia, elevated serum total bilirubin level, an enlarged right atrium, AF-d, and rAF are independent predictors of all-cause death in patients undergoing the maze IV procedure.

show abstract

Section: Discussionsupporting

confidence: 92%

Risk Factors for Prognosis after the Maze IV Procedure in Patients with Atrial Fibrillation Undergoing Valve Surgery

Zhou

2022

CVIA

View full text Add to dashboard Cite

show abstract

“…For linear ablation, 9 reports covered 443 patients 3–11 . The respective numbers for other techniques: focal 10 reports/508 patients 12–21 ; ostial isolation 343/2,187 22–55 ; circumferential including WACA/LACA 20/2,449 31,50,53,55–71 and PVAI 82/11,132; substrate ablation (CFAE) 8/559 51,152–158 ; and for surgical ablation 47/4,974 164–210 …”

Section: Resultsmentioning

confidence: 99%

“…Overall, 25% required repeat procedures. The surgical results are promising: 94% of patients who underwent AF ablation had structural heart disease (SHD), 81% had persistent or permanent AF; and yet 67% were “cured,” and 79% were considered OK at 6 months 164–210 . Monitoring for recurrence of AF at follow‐up may not always be as careful as in the catheter series, so results may be optimistic.…”

Section: Resultsmentioning

confidence: 99%

Atrial Fibrillation Ablation: Reaching the Mainstream

Fisher

Spinelli

Mookherjee

et al. 2006

Pacing Clinical Electrophis

View full text Add to dashboard Cite

show abstract

“…Beside isolation of the pulmonary veins, the procedural technique included ablation of the epicardial autonomic nervous system ganglion plexus and amputation of the left atrial appendage, which might account for slightly better results compared with our study. Szalay et al 19 showed that 71% of the patients remained in the SR or under atrial stimulation 12 months after mini-MAZE ablation. Jeanmart et al 20 performed mini-MAZE pulmonary vein isolation ablations in patients subjected to minimally invasive mitral valve surgery.…”

Section: Resultsmentioning

confidence: 99%